CoV-GLUE Lineage

CoV-GLUE Lineage: B.1.1.284

Table of countries and their respective (filtered) sequence count for the lineage 'B.1.1.284'.

Lineage	Country	Count	EarliestEpiWeek	LatestEpiWeek	View Mutations	20	21	22	23	24	25	26	27	28	29	30	31	32	33	34	35	36	37	38	39	40	41	42	43	44	45	46	47	48	49	50	51	52	53	54	55	56	57	58	59	60	61	62	63	64	65	66	67	68	69	70	71	72	73	74	75
B.1.1.284	All	9311	20	75	Mutations	1	1	6	24	60	102	82	148	228	454	512	1003	924	636	547	460	311	193	154	152	144	162	147	108	77	91	184	233	141	146	222	175	167	165	249	297	153	118	107	57	29	19	15	11	11	1	4	6	3	4	7	1	1	0	0	1
B.1.1.284	JAPAN	9300	20	75		1	1	6	24	60	102	82	148	228	452	512	1001	922	636	547	460	311	193	152	152	144	162	147	107	76	91	184	233	141	146	222	175	167	165	249	297	153	118	107	57	29	19	15	11	11	1	4	6	3	4	7	1	1	0	0	1
B.1.1.284	SOUTH_KOREA	4	29	43		0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B.1.1.284	AUSTRALIA	2	32	32		0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B.1.1.284	HONG_KONG	2	38	38		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B.1.1.284	THAILAND	2	31	31		0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B.1.1.284	SINGAPORE	1	44	44		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

CoV-GLUE is still in development. CoV-GLUE was originally developed as part of COG-UK by Josh Singer using the GLUE framework at the MRC-University of Glasgow Centre for Virus Research (CVR). In 2021 it was redeveloped by Richard Orton to scale to the millions of genome sequences available. We acknowledge support from the MRC (MC_UU_12014/12), WT (220977/Z/20/Z) and UKRI G2P (MR/W005611/1). Please contact Richard Orton with any queries: Richard.Orton@glasgow.ac.uk

CoV-GLUE uses sequence data from GISAID. GISAID data provided via this web application is subject to GISAID's Terms and Conditions.